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Introduction: This study focuses on the prevalence of pathogens colonising the
respiratory tract of adult CF patients at our specialist centre between 1985 and
2005. During this time, the care and treatment of patients with CF has continued to
evolve. Therefore, we hypothesised that sputum microbiology would have changed
and new pathogens may have emerged.
Method: A retrospective analysis using data from the Royal Brompton Hospital
CF database was performed.
Results: There were no signiﬁcant changes in the proportion of patients colonised
with Pseudomonas aeruginosa or Staphylococcus aureus between 1985 and 2005
(77 to 82%, p = 0.159; and 54% to 47%, p = 0.108 respectively). The prevalence
of Haemophilus inﬂuenzae (48 to 6%; p0.001) and Aspergillus species (18 to
9%; p = 0.002) decreased. Stenotrophomonas maltophilia and Methicillin-resistant
Staphylococcus aureus signiﬁcantly increased (1 to 4%, p = 0.02; and 1 to 6%,
p = 0.002, respectively). Burkholderia cepacia signiﬁcantly decreased (9% (1990)
to 4% (2005), p = 0.041). The mean FEV1 and body mass index increased (47 to
53% predicted, p = 0.0075; and 19 to 22, p< 0.001, respectively).
Conclusion: There has been relatively little change in the proportion of patients
with P. aeruginosa colonisation since 1985 and importantly, there has been a decline
in the prevalence of B. cepacia, H. inﬂuenzae and Aspergillus sp. The health status
of the patients has improved which, in part, may be due to the intensive antibiotic
strategy which, so far has not resulted in clinically signiﬁcant emergence of new
pathogens.
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Bacteriological monitoring of sputum in CF is the corner stone for therapeutical
and prognostic implications.
The aim of the study is to identify positive cultures of patients with CF and compare
results from the ﬁrst and second year.
Bacteriological results of sputum obtained, every three months, from 130 patients of
a pediatric CF center, during 2 years were included. Incidence of positive cultures
and bacteriological result (S.aureus, P.aeruginosa, B.cepacia complex and others)
were evaluated at each year and the results were compared. Incidence of MRSA
and of the 2 morphotypes of P.aeruginosa were analyzed and compared to the total
of S.aureus and P.aeruginosa, respectively.
During the 2 years the mean number of cultures/patients/year was more than four:
4.2−4.9. Cultures remained positive (81.7 and 77.9%) and showed more than one
bacteria (48.9 and 49%) on both years. Comparing cultures on both years there was
an increase in the number of cultures with Sa and Bc complex, and a decrease with
Pa. Both MRSA/total Sa (9.9→ 15.9%) and mucoid Pa/total Pa (47.3→ 51.6%)
proportions increased in the second year of study.
The systematic control of sputum collection permitted to reach the annual media
of 4 cultures/year/patient. The high positivity of cultures and their mix character
reinforce the importance of speciﬁc bacteriological processment of sputum of CF
patients. High frequency of MRSA, mucoid morphotype of Pa and Bc complex
emphasise the importance of the bacteriological monitoring in patients treatment
and segregation.
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Background: Nontuberculous Mycobacteria (NTM) have emerged as signiﬁcant
pathogens in cystic ﬁbrosis (CF) patients. This study is a 10-year retrospective
analysis of the clinical characteristics and microbiological data of patients attending
the Manchester Adult CF Centre from whom NTM was isolated.
Methods: Patients positive for NTM between 1997–2006 were identiﬁed from
the microbiology database. Case notes were studied for type of NTM, no. of
positive smears/cultures, sensitivities, co-pathogens, if receiving treatment with
TOBI, azithromycin or immunosuppressives, BMI, genotype, FEV1/FVC 1 year
pre and post culture, if diabetic and whether treatment was given/successful.
Results: NTM was cultured in 24 (14%) out of 320 patients. Mean age 28 years,
BMI 22 and FEV1 2.2 L post acquisition. 11 patients had diabetes, 10 were delta
F508/508. 6 patients had positive cultures from 1997–2001 and 18 from 2002–
2006. Types of NTM were 12 MAC, 9 chelonae, 3 abscessus, 1 gordonae and
1 malmoense. 12 (50%) patients were both smear and culture positive. Co-pathogens
were Pseudomonas N=22, Staphylococcus N=11 and Aspergillus N=13.
11 patients received treatment (mean age 29 years, BMI 21, FEV1 1.9 L) and
eradication occurred in 6 (2 chelonae, 3 MAC, 1 malmoense). 13 and 2 patients
were receiving azithromycin and TOBI respectively at the time of the ﬁrst positive
culture. The NTM became azithromycin resistant in 3 untreated patients taking
prophylactic monotherapy.
Conclusions: The incidence of NTM in our unit has increased over the past
10 years with MAC and M. chelonae predominating. Eradication treatment was
successful in 50% of patients. Azithromycin resistance may develop in patients
taking monotherapy.
190 Occurrence of fungi in the respiratory tract of adults with
cystic ﬁbrosis
E. Sauteur1, M. Baixench1, D. Hubert2, N. Desmazes-Dufeu2, R. Kanaan2,
A. Paugam1. 1Parasitologie-Mycologie, Hoˆpital Cochin, APHP, Paris, France;
2Pneumologie, Hoˆpital Cochin, APHP, Paris, France
Objective: Frequency and characteristics of fungi isolated from sputum in adults
with cystic ﬁbrosis (CF) were retrospectively investigated.
Material and Methods: Mycological data from CF patients followed at our French
University Hospital over a two year period (2005–2006) was extracted from our
laboratory computer.
201 patients were included: 47% women and 53% men, 17 to 65 years old. A total
of 657 respiratory samples were analysed.
Results: Positive fungal samples were observed in 94.5% (190/201) of the patients.
Filamentous fungi were isolated from 65.6% (132/201). 48.2% (97/201) of the
patients had only one species whereas 17.4% (35/201) had more than one species.
Aspergillus fumigatus was the predominant species for 56.7% (114/201) of the
patients. Other Aspergillus species (A. ﬂavus, A. niger, A. nidulans, A. terreus,
and A. versicolor) were isolated from only 9.4% (19/201) of the patients. Sce-
dosporium spp. were isolated from 3.4% (7/201) of the patients. The proportion of
positive samples by patient for A. fumigatus and Sedosporium spp. were 71% and
58% respectively contrary to the other ﬁlamentous fungi with a proportion of 23%.
Yeasts were isolated from 72.4% (152/210) patients.
Candida albicans was the predominant species for 72.1% (145/201) of the patients.
The proportion of positive samples by patient was 66% for C. albicans and only
27% for non-albicans spp.
Conclusion: The occurrence of fungi in the respiratory tract of CF adults is very
high, mainly represented by A. fumigatus and C. albicans which are continuously
isolated in most of the patients.
